Nanexa AB

As of June 30, 2026, Nanexa AB carries a market capitalization of 670.78M, placing it among publicly traded companies globally. Its enterprise value stands at 619.01M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Nanexa AB's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Nanexa AB has 184.79M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 18.19, and the price-to-book ratio stands at 5.05.

These figures are as of June 30, 2026. The EV/Sales ratio of 18.29 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 619.01M versus a market cap of 670.78M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Nanexa AB maintains a current ratio of 2.89, meaning it holds 2.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.60, indicating moderate leverage, while an interest coverage ratio of -4.24 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Nanexa AB posted a negative return on equity (ROE) of -22.05, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -17.46, reflecting losses generated across the asset base. The company generates approximately 2.33M in revenue per employee across its workforce of 14.50, a quick read on workforce productivity versus industry peers. Inventory turnover of -62.53 indicates how many times Nanexa AB sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Nanexa AB recorded an income tax benefit of -108,000.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -24.67M and -24.56M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Nanexa AB's stock has gained approximately 458.95% over the past 52 weeks. The 50-day moving average sits at 7.51, while the 200-day moving average is 4.75.

Over the twelve months ended June 30, 2026, Nanexa AB generated 33.85M in revenue and converted that into -24.56M in net income, yielding earnings per share of -0.14. EBITDA reached -9.79M, while operating income came in at -22.81M.

As of June 30, 2026, Nanexa AB holds 52.56M in cash and equivalents against 795,000.00 in total debt, resulting in a net debt position of -4.06M. Total book value stands at 132.87M, with working capital of 39.66M providing operational flexibility.

Nanexa AB produced -6.44M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -27.33M in capital expenditures, free cash flow totaled -33.76M - equivalent to -0.20 per share.

Over the twelve months ended June 30, 2026, Nanexa AB posted a gross margin of 152.64, reflecting its pricing power and cost economics. The operating margin of -67.39 and net profit margin of -72.54 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -5.16: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -6.87, meaning Nanexa AB raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Nanexa AB's most recent stock split took place on June 11, 2021 with a 27:29 split ratio.

As of June 30, 2026, Nanexa AB has an Altman Z-Score of 11.49, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.